Aurora Cannabis Inc (NASDAQ: ACB)’s stock price has gone rise by 3.03 in comparison to its previous close of 5.95, however, the company has experienced a 10.05% increase in its stock price over the last five trading days. prnewswire.com reported 2025-06-05 that NASDAQ | TSX: ACB Canada’s Largest Medical Cannabis Company Adds Two New Cultivars to Popular Brand Portfolio in the Australian Market EDMONTON, AB, June 5, 2025 /PRNewswire/ – Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has expanded their popular IndiMed brand with the launch of IndiMed TEMPO 22, available through the company’s subsidiary, MedReleaf Australia. With the same consistent quality and reliable supply, this new 22% THC potency creates a greater range of treatment options available to prescribers.
Is It Worth Investing in Aurora Cannabis Inc (NASDAQ: ACB) Right Now?
Aurora Cannabis Inc (NASDAQ: ACB) has a higher price-to-earnings ratio of 38.90x compared to its average ratio. ACB has 36-month beta value of 1.84. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for ACB is 54.67M, and currently, short sellers hold a 9.39% ratio of that float. The average trading volume of ACB on June 11, 2025 was 957.26K shares.
ACB’s Market Performance
The stock of Aurora Cannabis Inc (ACB) has seen a 10.05% increase in the past week, with a 21.15% rise in the past month, and a 39.32% gain in the past quarter. The volatility ratio for the week is 3.49%, and the volatility levels for the past 30 days are at 3.03% for ACB. The simple moving average for the past 20 days is 12.80% for ACB’s stock, with a 23.49% simple moving average for the past 200 days.
ACB Trading at 25.95% from the 50-Day Moving Average
After a stumble in the market that brought ACB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -14.86% of loss for the given period.
#####
#####
Stock Fundamentals for ACB
Current profitability levels for the company are sitting at:
- 0.12 for the present operating margin
- 0.68 for the gross margin
The net margin for Aurora Cannabis Inc stands at 0.03. The total capital return value is set at 0.05. Equity return is now at value 4.78, with 3.09 for asset returns.
Based on Aurora Cannabis Inc (ACB), the company’s capital structure generated 0.15 points at debt to capital in total, while cash flow to debt ratio is standing at -0.09. The debt to equity ratio resting at 0.18. The interest coverage ratio of the stock is 4.89.
Currently, EBITDA for the company is -12.34 million with net debt to EBITDA at -0.13. When we switch over and look at the enterprise to sales, we see a ratio of 1.41. The receivables turnover for the company is 6.47for trailing twelve months and the total asset turnover is 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.30.
Conclusion
To put it simply, Aurora Cannabis Inc (ACB) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
